J. Couquelet

发表

Novel 4,5-diaryl-3-hydroxy-2(5H)-furanones as anti-oxidants and anti-inflammatory agents.

É. Albuisson, M. Bria, E. Duroux, 2002, Bioorganic & medicinal chemistry.

Synthesis and analgesic effects of 3-substituted 4,6-diarylpyridazine derivatives of the arylpiperazine class.

P. Coudert, C. Rubat, J. Couquelet, 1997, Bioorganic & medicinal chemistry.

Synthesis and anticonvulsant properties of triazolo- and imidazopyridazinyl carboxamides and carboxylic acids.

S. Moreau, P. Coudert, D. Gardette, 1998, Bioorganic & medicinal chemistry.

Synthesis of new 2‐aryl‐3,3a‐dihydro‐4‐oxo‐5H‐pyrazolo‐[1,5‐d][1,2,4]triazines and some of their derivatives

S. Mavel, J. Bastide, P. Coudert, 1991 .

Comparative effects of some 3-amino 4,6-diarylpyridazines on the biosynthesis in vitro of TXA2 and PGI2- and on the TXA2- and PGI2-synthesizing activities of cardiac tissue.

R. Chahine, R. Kaiser, P. Coudert, 1990, Prostaglandins, leukotrienes, and essential fatty acids.

A selective inhibitor of thromboxane synthetase activity of rabbit heart tissue: a pyridazinic derivative.

B. Lasserre, C. Rubat, J. Couquelet, 1988, Prostaglandins, leukotrienes, and essential fatty acids.

An inhibitor of prostacyclin biosynthesis derived from aminopyridazine.

P. Chanh, B. Lasserre, J. Couquelet, 1987, Prostaglandins, leukotrienes, and medicine.

Enhanced prostacyclin biosynthesis and decreased thromboxane formation by 3-dimethylamino 5-(2',6'-dichlorobenzylidene) 6-methyl (4H)-pyridazine (PC 89).

B. Lasserre, J. Couquelet, P. Tronche, 1985, Prostaglandins, leukotrienes, and medicine.

Synthesis and analgesic effect of N-substituted 5-arylidene-6-methyl-3-(4H)-pyridazinones.

J. Bastide, P. Coudert, C. Rubat, 1988, Chemical & pharmaceutical bulletin.

5‐(2‐Chlorobenzyl)‐6‐methyl‐3(2H)‐pyridazinone

S. Moreau, J. Métin, P. Coudert, 1995 .

Pharmacophore requirements in new series of pyridazinyl alkanoic acids, N-[(pyridazin-2-yl) alkyl] succinyl and glutaryl amides, inhibitors of thromboxane A2 biosynthesis.

S. Moreau, P. Coudert, B. Lasserre, 1997, Prostaglandins, Leukotrienes and Essential Fatty Acids.

[Synthesis and anti-allergic properties of N-arylnitrones with furo-pyran structure].

J. Fialip, J. Bastide, P. Coudert, 1988, Annales Pharmaceutiques Françaises.

[Synthesis and anticoagulant effect of some chromone-2-carboxylic acid amides].

J. Couquelet, P. Tronche, P. Jolland, 1965, Annales pharmaceutiques francaises.

[Synthesis and evaluation of the aldose reductase inhibitory activity of new diaryl pyridazine-3-ones].

E. Duroux, P. Coudert, J. Couquelet, 1991, Journal de pharmacie de Belgique.

Antioxidant Properties of Novel Lipophilic Ascorbic Acid Analogues

E. Duroux, P. Coudert, V. Weber, 2000, The Journal of pharmacy and pharmacology.

Synthesis and pharmacological evaluation of 6,8-diaryl 1,2,4-triazolo [4,3,-b] and 1,2,3,4,-tetrazolo [1,5-b] pyridazines.

J. Bastide, P. Coudert, C. Rubat, 1990, Farmaco.

Study of structure/activity relationships by multivariate statistical analysis in a series of triazaspirodecanediones with CNS activities.

J. Dore, C. Viel, P. Coudert, 1994, Pharmaceutica acta Helvetiae.

Antioxidant activity of some ascorbic and cinnamic acids derivatives.

V. Sautou-Miranda, J. Chopineau, P. Coudert, 1998, Farmaco.

Synthesis of new pyrrolo[1,2-d][1,2,4]triazines and thiazolo[3,4-d][1,2,4]triazines as immunostimulating agents.

E. Seillès, P. Coudert, J. Couquelet, 1998, Bioorganic & medicinal chemistry.